间充质基质细胞表达基质细胞衍生因子-1影响脓毒症期间中性粒细胞功能
该研究为动物实验与细胞培养,采用盲肠结扎穿刺诱导 BALB/c 小鼠多微生物脓毒症,经尾静脉注射对照短发夹结构间充质基质细胞或沉默基质细胞衍生因子-1的间充质基质细胞。结果显示,注射对照间充质基质细胞的小鼠7天生存率为70%,而注射沉默基质细胞衍生因子-1间充质基质细胞的小鼠生存率显著降低至33%,且细菌清除效率下降、中性粒细胞吞噬细菌能力受损、腹腔中性粒细胞增多且更不成熟,骨髓细胞减少且中性粒细胞死亡增加。结论认为间充质基质细胞表达基质细胞衍生因子-1可增强中性粒细胞功能、提高细菌清除并保护骨髓细胞储备。
要点
- 脓毒症小鼠注射对照间充质基质细胞后7天生存率为70%,而注射沉默基质细胞衍生因子-1间充质基质细胞的小鼠生存率显著降低至33%。
- 沉默基质细胞衍生因子-1的间充质基质细胞导致脓毒症小鼠细菌清除效率较对照间充质基质细胞下降。
- 对照间充质基质细胞或其条件培养基可增强中性粒细胞对细菌的吞噬,而沉默基质细胞衍生因子-1后该效应显著减弱。
- 注射沉默基质细胞衍生因子-1间充质基质细胞的小鼠腹腔中性粒细胞显著增多且更不成熟,骨髓细胞减少且中性粒细胞死亡增加。
适用人群与场景
- 盲肠结扎穿刺诱导多微生物脓毒症的 BALB/c 小鼠(动物实验与细胞培养)。
处置流程与药物剂量
- 脓毒症发作后经尾静脉注射对照短发夹结构间充质基质细胞或沉默基质细胞衍生因子-1的间充质基质细胞。
研究设计与关键结果
- 动物实验与细胞培养:盲肠结扎穿刺诱导 BALB/c 小鼠多微生物脓毒症,经尾静脉注射对照短发夹结构间充质基质细胞或沉默基质细胞衍生因子-1的间充质基质细胞,评估生存、细菌清除、炎症反应及中性粒细胞吞噬功能。
- 注射对照短发夹结构间充质基质细胞的小鼠7天生存率为70%,而注射沉默基质细胞衍生因子-1间充质基质细胞的小鼠生存率显著降低至33%。
- 沉默基质细胞衍生因子-1间充质基质细胞组小鼠的生存获益丧失与细菌清除效率较对照短发夹结构间充质基质细胞组下降相关。
- 对照短发夹结构间充质基质细胞或其条件培养基可增强中性粒细胞对细菌的吞噬,而沉默基质细胞衍生因子-1后该效应显著减弱。
- 注射沉默基质细胞衍生因子-1间充质基质细胞的小鼠腹腔中性粒细胞显著增多且更不成熟,该反应与骨髓细胞减少及中性粒细胞死亡增加相关。
证据类型、等级与局限
- 证据类型:动物实验与细胞培养。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文结论认为,间充质基质细胞表达基质细胞衍生因子-1可增强中性粒细胞吞噬功能、提高细菌清除效率并保护脓毒症期间骨髓细胞储备免于耗竭。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Sepsis results in organ dysfunction caused by a dysregulated host response, in part related to the immune response of a severe infection. Mesenchymal stromal cells are known to modulate the immune response, and expression of stromal cell-derived factor-1 regulates mobilization of neutrophils from the bone marrow. We are investigating the importance of stromal cell-derived factor-1 in mesenchymal stromal cells and its role in promoting neutrophil function after the onset of cecal ligation and puncture-induced sepsis. Stromal cell-derived factor-1 expression was silenced in mesenchymal stromal cells, compared with the control scrambled construct mesenchymal stromal cells.
DESIGN: Animal study and cell culture.
SETTING: Laboratory investigation.
SUBJECTS: BALB/c mice.
INTERVENTIONS: Polymicrobial sepsis was induced by cecal ligation and puncture. shSCR mesenchymal stromal cells and shSDF-1 mesenchymal stromal cells were delivered by tail vein injections to septic mice. The mice were assessed for survival, bacterial clearance, and the inflammatory response during sepsis in each of the groups. Mesenchymal stromal cells were also assessed for their ability to promote bacterial phagocytosis by neutrophils.
MEASUREMENTS AND MAIN RESULTS: Injection of shSCR mesenchymal stromal cells after the onset of sepsis led to an increase in mouse survival (70%) at 7 days, whereas survival of mice receiving shSDF-1 mesenchymal stromal cells was significantly diminished (33%). The loss of survival benefit in mice receiving shSDF-1 mesenchymal stromal cells was associated with less efficient bacterial clearance compared with shSCR mesenchymal stromal cells. Although shSCR mesenchymal stromal cells, or their conditioned medium, were able to increase neutrophil phagocytosis of bacteria, this effect was significantly blunted with shSDF-1 mesenchymal stromal cells. Assessment of peritoneal inflammation revealed that neutrophils were significantly increased and more immature in septic mice receiving shSDF-1 mesenchymal stromal cells. This response was associated with hypocellularity and increased neutrophil death in the bone marrow of mice receiving shSDF-1 mesenchymal stromal cells.
CONCLUSIONS: Expression of stromal cell-derived factor-1 in mesenchymal stromal cells enhances neutrophil function with increased phagocytosis, more efficient clearance of bacteria, and bone marrow protection from depletion of cellular reserves during sepsis.
参考来源
- Kwon MY, Ghanta S, Ng J, et al. Expression of Stromal Cell-Derived Factor-1 by Mesenchymal Stromal Cells Impacts Neutrophil Function During Sepsis. Crit Care Med. 2020. PMID: 32167490. doi:10.1097/CCM.0000000000004244
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。